NCT04065269 2026-02-20ATARIInstitute of Cancer Research, United KingdomPhase 2 Active not recruiting174 enrolled
NCT04483544 2025-04-29Pembrolizumab and Olaparib in Cervical Cancer PatientsBaptist Health South FloridaPhase 2 Terminated8 enrolled 13 charts